Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$66.68
-1.1%
$65.14
$43.56
$72.51
$85.30B0.5710.83 million shs6.42 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$155.23
-0.5%
$153.67
$140.68
$169.99
$375.37B0.418.05 million shs6.26 million shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
0.00%-1.65%+5.92%+5.61%+19.00%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+2.27%+0.57%+3.61%+6.43%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CVS Health Corporation stock logo
CVS
CVS Health
4.9791 of 5 stars
3.53.03.33.92.23.33.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.956 of 5 stars
3.35.04.23.93.01.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.95
Moderate Buy$75.3813.04% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$170.8810.08% Upside

Current Analyst Ratings Breakdown

Latest JNJ and CVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
CVS Health Corporation stock logo
CVS
CVS Health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$74.00 ➝ $80.00
6/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
6/2/2025
CVS Health Corporation stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$82.00 ➝ $79.00
5/13/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/13/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$169.00 ➝ $153.00
5/12/2025
CVS Health Corporation stock logo
CVS
CVS Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$82.00 ➝ $84.00
5/6/2025
CVS Health Corporation stock logo
CVS
CVS Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$76.00 ➝ $84.00
5/5/2025
CVS Health Corporation stock logo
CVS
CVS Health
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/5/2025
CVS Health Corporation stock logo
CVS
CVS Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$74.00 ➝ $81.00
5/2/2025
CVS Health Corporation stock logo
CVS
CVS Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$67.00 ➝ $71.00
5/2/2025
CVS Health Corporation stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$73.00 ➝ $82.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$378.96B0.22$8.99 per share7.42$60.18 per share1.11
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.21$13.06 per share11.89$29.69 per share5.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$4.61B$4.1915.919.850.971.39%10.59%3.17%7/31/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9917.2714.022.3624.42%33.46%13.30%7/16/2025 (Estimated)

Latest JNJ and CVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.45N/AN/AN/A$94.87 billionN/A
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.65N/AN/AN/A$22.85 billionN/A
5/1/2025Q1 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.62$2.25+$0.63$1.41$93.07 billion$94.59 billion
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.663.99%N/A63.48%4 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.35%N/A57.84%64 Years

Latest JNJ and CVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/7/2025
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66503.99%7/22/20258/1/2025
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.77
0.82
0.63
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.26
1.03

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
1.22%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.27 billion1.25 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVS Health stock logo

CVS Health NYSE:CVS

$66.68 -0.75 (-1.11%)
Closing price 03:59 PM Eastern
Extended Trading
$66.49 -0.19 (-0.28%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$155.23 -0.78 (-0.50%)
Closing price 03:59 PM Eastern
Extended Trading
$154.26 -0.97 (-0.63%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.